News

Schouw & Co. Updates Long-Term Incentive Strategy for 2024

Schouw & Co. Updates Long-Term Incentive Strategy for 2024

Overview of the Restructured Incentive Programme

Schouw & Co. has been dedicated to cultivating long-term growth through its incentive programmes since 2003. These initiatives are aimed primarily at senior managers across the organization. As we look ahead to 2024, the incentive programme has undergone significant restructuring to create a more direct correlation with the performance of individual portfolio companies, offering a fresh approach to incentivization.

Performance Share Units: A Shift in Strategy

The Board of Directors has introduced an updated model for the long-term incentive programme of the Group’s parent company. Unlike before, where share options were the core component, the new model emphasizes the granting of Performance Share Units (PSUs). Such a structure aligns with practices widely adopted by major Danish listed companies, allowing for a streamlined approach that encourages performance enhancement among senior management.

Incentives Aligned with Shareholder Interests

The primary goal of the revamped long-term incentive programme is to foster value creation within Schouw & Co. This restructuring is designed to synchronize the objectives of senior managers with the interests of shareholders, promoting a culture of shared success.

Details of the Performance Share Units

Under the new plan, three senior managers from the parent company are set to receive a total of 18,600 PSUs. Notably, Jens Bjerg Sørensen, the CEO & President, is awarded 12,200 PSUs. These PSUs provide participants with the conditional right to receive shares at no cost, contingent upon certain performance metrics and the approval of the annual financial report for the year 2027.

Importantly, the maximum grant for each participant cannot exceed 75% of their annual base salary. This structure not only motivates individuals to excel but also frames their success within the financial health of the company.

Performance Metrics and Evaluation

The effectiveness of the incentive programme is determined using key performance indicators (KPIs), focusing on achieving goals over the establishment period of 2025 to 2027. The KPIs for the upcoming programme have been bifurcated into three critical categories: EBITDA and Return on Invested Capital (ROIC), both weighted at 40%, and Total Shareholder Return at 20%. The theoretical valuation of the programme extends between zero and DKK 12 million, validating the financial integrity and ambition of the initiative.

Continued Employment and Good Leaver Provision

To maintain the integrity of this programme, vesting of the PSUs hinges on continuous employment with a group company throughout the vesting period. Participants are required to adhere to the programme's terms consistently. However, provisions are in place for individuals categorized as Good Leavers; they may still retain a proportional share of the PSUs based on their duration of employment during the performance period.

Company Leadership and Contact Information

Leadership plays a pivotal role in ensuring the programme's success. The Board of Directors is led by Chairman Jørgen Dencker Wisborg, alongside Jens Bjerg Sørensen, who continues to steer the company as President & CEO. For inquiries related to the incentive programme, Jens Bjerg Sørensen can be reached directly at +45 8611 2222, providing a clear line of communication for any further information.

Frequently Asked Questions

What is the main goal of the restructured incentive programme?

The primary goal is to align the interests of senior managers with those of the shareholders while promoting a culture of value creation.

How are the Performance Share Units granted?

Performance Share Units are granted conditionally, with a maximum that cannot exceed 75% of the participant's annual base salary.

What key performance indicators are utilized?

KPIs include EBITDA, Return on Invested Capital (ROIC), and Total Shareholder Return, which drive the assessment of performance over the specified years.

What happens if a participant leaves the company?

Participants designated as Good Leavers can retain a proportional share of their PSUs based on their employment duration during the performance period.

Who can I contact for more information about the programme?

For questions regarding the incentive programme, you can contact Jens Bjerg Sørensen, the CEO, at +45 8611 2222.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib

Updated Category News Views 264

Promising Advances in Breast Cancer Treatment Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a pioneering biopharmaceutical company specializing in breast cancer therapies, recently revealed compelling data from its Phase 1b/2 trial examining the effects of palazestrant combined with ribociclib in patients battling estrogen...

Continue Reading
Recent Share Transactions by Danske Bank Management Team

Updated Category News Views 135

Recent Share Transactions by Danske Bank Management Team Danske Bank A/S has been making headlines with its ongoing share buy-back program, a key strategic move aimed at enhancing shareholder value. As management and executives involve themselves in these transactions, it is essential to stay informed about their actions, which are a reflection of the company's health and...

Continue Reading
Purpose Legal's PurposeXi: AI-Driven Legal Revolution or Just Hype?

Updated Category News Views 171

Purpose Legal just unveiled PurposeXi™ on February 17, 2026—this shiny new tool aims to revolutionize the legal landscape by integrating AI across the board. Traders are raising eyebrows because while they tout speed and efficiency, we've seen this play before. Remember when tech made bold claims but left investors hanging when reality hit? Well, buckle up....

Continue Reading
PowerBank's Vision for Dominating the Data Center Industry

Updated Category News Views 138

Insight into the Data Center Market PowerBank Corporation (NASDAQ: SUUN) is stepping into the spotlight as a key player in the rapidly expanding data center market. The company is poised to leverage its expertise in energy infrastructure development and asset ownership to address the rising demand for power supply in data centers. Projections suggest that the data center...

Continue Reading
Exploring the Promising Landscape of Adenosine Antagonists

Updated Category News Views 156

Introduction to Adenosine Antagonists Adenosine antagonists represent a fascinating domain in medical research, particularly due to their potential implications across various therapeutic areas. As these compounds inhibit adenosine—a nucleoside that governs essential physiological functions—they may revolutionize treatment options for diseases such as cancer,...

Continue Reading